Results 21 to 30 of about 88,763 (308)

The association between sarcopenia and incident chronic lung disease in the general population: A longitudinal study based on CHARLS data

open access: yesExperimental Gerontology, 2023
Background: Data regarding the association of sarcopenia with chronic lung disease (CLD) has led to inconclusive results. The main goal of this research was to investigate the association between sarcopenia and CLD in middle-aged and elderly individuals ...
Hongxiang Wang   +4 more
doaj   +1 more source

Sarcopenia is Related to Increased Risk for Low Bone Mineral Density [PDF]

open access: yes, 2014
Lean body mass is positively correlated with bone mineral density (BMD). The association between sarcopenia and BMD is less studied. The aim of the study is to investigate the association between sarcopenia and abnormal BMD.
蔡克嵩 ;黃國晉 ;張皓翔   +1 more
core   +1 more source

Sarcopenia

open access: yesNature Reviews Disease Primers
Sarcopenia is the accelerated loss of skeletal muscle mass and function commonly, but not exclusively, associated with advancing age. It is observed across many species including humans in whom it can lead to decline in physical function and mobility as well as to increased risk of adverse outcomes including falls, fractures and premature mortality ...
Avan A. Sayer   +8 more
openaire   +8 more sources

Sarcopenic Obesity Defined by Japanese Working Group on Sarcopenic Obesity in Post-Stroke Inpatients: Prevalence and Clinical Implications [PDF]

open access: yesAnnals of Geriatric Medicine and Research
Background Sarcopenic obesity (SO) is characterized by the coexistence of sarcopenia and obesity, associated with adverse health outcomes. This study aimed to investigate the prevalence of SO as defined by the recently published Japanese Working Group on
Ayaka Matsumoto   +10 more
doaj   +1 more source

Sarcopenia in COPD [PDF]

open access: yesThorax, 2015
Dear Editor, We read with great interest the paper by Jones et al 1 about the prevalence, clinical correlates and response to pulmonary rehabilitation of sarcopenia in COPD. We believe that authors have meritoriously focused their attention on a highly relevant topic, which is the skeletal muscle decline in patients with COPD. Sarcopenia represents a
Scarlata, S.   +2 more
openaire   +3 more sources

Managing Sarcopenia and Its Related-Fractures to Improve Quality of Life in Geriatric Populations [PDF]

open access: yes, 2014
Sarcopenia, an aging-induced generalized decrease in muscle mass, strength, and function, is known to affect elderly individuals by decreasing mobile function and increasing frailty and imbalance that lead to falls and fragile fractures.
Ishiguro, Naoki   +3 more
core   +1 more source

Sarcopenia and the Brain [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 2021
The term sarcopenia (“a poverty of flesh”) was first described by Irving Rosenberg in 1989. In its original format it was limited to an aging related loss of muscle that was associated with functional deterioration and earlier mortality. In 2010, the European Working Group on Sarcopenia in Older Persons (EWGSOP) published a consensus definition on ...
openaire   +4 more sources

EFFECTS OF LEUCINE SUPPLEMENTATION AND RESISTANCE TRAINING TO COUNTERACT SARCOPENIA [PDF]

open access: yes, 2022
openLa sarcopenia, ossia la diminuzione di forza e/o massa muscolare che si verifica con l’invecchiamento, rappresenta una realtà sempre più frequente tra le classi anziane e di interesse per i sistemi sanitari.
TOMMASINI, ENRICO
core  

Sarcopenia Screened With SARC-F Questionnaire Is Associated With Quality of Life and 4-Year Mortality [PDF]

open access: yes, 2017
Objectives: There is no gold standard in diagnosing sarcopenia. We aimed to assess the validity of screening sarcopenia using SARC-F (sluggishness, assistance in walking, rise from a chair, climb stairs, falls).
季瑋珠;楊榮森   +1 more
core   +1 more source

Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease [PDF]

open access: yes, 2021
Background: Sarcopenia is a significant indicator of the severity of non-alcoholic fatty liver disease. We investigated whether sarcopenia could identify subgroups with different risk of liver fibrosis and atherosclerotic cardiovascular disease (ASCVD ...
안상훈   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy